IMMUNESTRATIFY

IMMUNESTRATIFY The molecular immune signature in ME/CFS as stratification tool for future personalized treatment

Background

About the study

ME/CFS is a disease in which people can experience a wide range of symptoms, suggesting that there may be multiple subtypes of the disease. The researchers will address two key questions:

  1. Can people with ME/CFS be classified into subgroups based on their immune signatures? The researchers will investigate whether people with ME/CFS can be classified based on previously identified immune signatures found in patients with other diseases that also cause severe fatigue. They will also examine whether specific symptoms can be linked to these immune signatures.
  2. Are immune cells from people with ME/CFS hypersensitive to stimuli, leading to the production of pathogenic inflammatory substances?

For this project blood samples from the people with ME/CFS from the NMCB will be studied. This project aims to improve our understanding on the role of the immune system in ME/CFS and provide clues for the development of new treatments. The immune signatures detected in ME/CFS patients will be made available as a diagnostic test.

Subproject

Team

Bart Humer

Bart Humer

PhD Student

Wim Dik

Dr. Wim Dik

Laboratory specialist in medical immunology

Dr. Marjan Versnel

Principal investigator